Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

81.06EUR
25 Apr 2018
Change (% chg)

-- (--)
Prev Close
€81.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
648,711
52-wk High
€93.82
52-wk Low
€76.42

Summary

Name Age Since Current Position

Gerd Krick

79 1998 Chairman of the Supervisory Board

Rice Powell

62 2013 Chairman of the Management Board, Chief Executive Officer

Ben Lipps

78 2013 Honorary Chairman

Dieter Schenk

65 1996 Vice Chairman of the Supervisory Board

Michael Brosnan

62 2010 Chief Financial Officer, Member of the Management Board

Olaf Schermeier

45 2013 Chief Executive Officer for Global Research and Development, Member of the Management Board

Harry de Wit

55 2016 Chief Executive Officer for Asia-Pacific, Member of the Management Board

William Valle

57 2017 Chief Executive Officer for North America, Member of the Management Board

Kent Wanzek

59 2010 Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board

Rolf Classon

72 2011 Independent Member of the Supervisory Board

Deborah Doyle McWhinney

62 2016 Independent Member of the Supervisory Board

William Johnston

73 2006 Independent Member of the Supervisory Board

Pascale Witz

51 2016 Independent Member of the Supervisory Board

Dominik Heger

2016 Senior Vice President

Biographies

Name Description

Gerd Krick

Dr. Gerd Krick has been Independent Chairman of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA since January 1, 1998. Additionally, Dr. Krick acts as Member of the Audit and Corporate Governance Committee, as well as Chairman of the Nominating Committee at the Company. He was Chairman of the Fresenius AG Management Board from 1992 to May 2003 at which time he became Chairman of the Supervisory Board. Prior to 1992, he was a Director of the Medical Systems Division of Fresenius AG and Deputy Chairman of the Fresenius AG Management Board. From September 1996 until December 1997, Dr. Krick was Chairman of the Management Board of Fresenius Medical Care. Dr. Krick was Member of the Advisory Board of HDI V.a.G until December 31, 2008, and Member of the Supervisory Board of Allianz Private Kankenversicherungs-AG until April 16, 2008. He is Member of the Supervisory Boards of Fresenius Management SE (Chairman), Fresenius SE & Co. KGaA (Chairman), Fresenius Medical Care Management AG and Vamed AG, Austria (Chairman).

Rice Powell

Mr. Rice Powell has been Chief Executive Officer and Chairman of the Management Board at Fresenius Medical Care AG & Co. KGaA since January 1, 2013. Prior to that, he served as Deputy Chairman of the Management Board at the Company and Chief Executive Officer of Fresenius Medical Care North America from January 1, 2010. Previously he acted as Member of the Management Board of Fresenius Medical Care AG & Co. KGaA, Chief Executive Officer of Renal Therapy Group of Fresenius Medical Care in North America. He has been representative of Fresenius Medical Care Management AG, general partner of the Company. He joined Fresenius Medical Care in 1997 and was appointed co-CEO and Member of the Management Board of Fresenius Medical Care North America on January 1, 2004. Mr. Powell has experience in the healthcare industry. From 1978 to 1996 he held various positions within Baxter International Inc, Biogen Inc, and Ergo Sciences Inc, the United States, among others. He is Member of the Management Boards of Fresenius Medical Care Holdings, Inc., U. S. ( Chairman of the Board of Directors ), Fresenius Management SE, General Partner of Fresenius SE & Co. KGaA, Member of the Board of Administration of Vifor Fresenius Medical Care Renal Pharma Ltd., Switzerland (Vice Chairman).

Ben Lipps

Dr. Ben J. Lipps has been Honorary Chairman of Fresenius Medical Care AG & Co. KGaA since January 1, 2013. After earning his Master and Doctoral degrees at the Massachusetts Institute of Technology in Chemical Engineering, Dr. Lipps led the research team that developed the first commercial Hollow Fiber Artificial Kidney at the end of the 1960s at DOW Chemical. Dr. Lipps has held the position of Chairman of the Management Board of Fresenius Medical Care Holdings Inc., USA and Member of the Management Board of Fresenius Management SE. He has also acted as Member of the Board of Vifor Fresenius Medical Care Renal Pharma Ltd.

Dieter Schenk

Dr. Dieter Schenk has been Vice Chairman of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA since 1996. He is Vice Chairman of the Nominating Committee at the Company. He is an attorney and tax advisor and has been a partner in the law firm of Noerr Stiefenhofer Lutz since 1986. He has been Member of the Supervisory Boards of Fresenius Management SE (Vice Chairman), Fresenius Medical Care Management AG (Vice Chairman), Bank Schilling & Co. AG (Chairman), Gabor Shoes AG (Chairman), Greiffenberger AG (Vice Chairman, until May 7, 2017) and TOPTICA Photonics AG (Chairman).

Michael Brosnan

Mr. Michael Brosnan is Chief Financial Officer and Member of the Management Board at Fresenius Medical Care AG & Co. KGaA since January 1, 2010. Previously, he served as Chief Financial Officer of Fresenius Medical Care North America for seven years. He joined the Company in 1998 as vice president of Finance and Administration for Spectra Renal Management, the company’s laboratory services organization. Subsequently, he assumed several executive functions at Fresenius Medical Care North America. Prior to joining the company, he held senior financial positions at Polaroid Corporation and was an audit partner at KPMG. He is Member of the Management Board of Fresenius Medical Care Holdings, Inc., U. S. (Member of the Board of Directors) and Member of the Board of Administration of Vifor Fresenius Medical Care Renal Pharma Ltd., Switzerland.

Olaf Schermeier

Dr. Olaf Schermeier has been Member of the Management Board and Chief Executive Officer for Research and Development at Fresenius Medical Care AG & Co. KGaA since March 1, 2013. Previously, he served as president of global R&D for Draeger Medical, Luebeck, Germany. Dr. Schermeier has many years of experience in various areas of the health care industry, among others at Charite-clinic and Biotronik, Germany. He holds a doctorate degree (Ph.D.) in Computer Science from the Technical University of Berlin, Germany and graduated from the University of Hannover, Germany in Electrical Engineering. He is Member of the Supervisory Board of Xenios AG (Vice Chairman) and Medos Medizintechnik AG (Vice Chairman).

Harry de Wit

Mr. Harry de Wit has been Member of the Management Board and Chief Executive Officer for Asia-Pacific at Fresenius Medical Care AG & Co. KGaA since April 1, 2016. He has worked in various areas in the medical device industry for over 25 years. Previously, Mr. de Wit served as President Asia at Covidien (now Medtronic) in Singapore. He holds a Master’s degree in Medicine from the VU University of Amsterdam, the Netherlands and a Bachelor’s of Science in Physiotherapy from the School of Physiotherapy of Den Bosch, Netherlands. He is Member of the Board of Directors of New Asia Investments Pte Ltd., Singapore.

William Valle

Mr. William (Bill) Valle has been Member of the Management Board and Chief Executive Officer for North America of Fresenius Medical Care AG & Co. KGaA since February 17, 2017. Prior to that, he was executive vice president responsible for the dialysis service business and vascular access business of Fresenius Medical Care North America from 2014 to 2017. Bill joined Fresenius Medical Care in 2009 and has nearly 30 years of experience in the dialysis industry, holding executive positions in sales, marketing and business development at several dialysis companies including Gambro Healthcare, Inc. He is Member of the Management Board of : Fresenius Medical Care Holdings, Inc., U. S. (Member of the Board of Directors, since January 14, 2017).

Kent Wanzek

Mr. Kent Wanzek has been Member of the Management Board and Chief Executive Officer for Global Manufacturing Operations at Fresenius Medical Care AG & Co. KGaA since January 1, 2010. From 2004 onwards, he was in charge of North American operations for the Renal Therapies Group at Fresenius Medical Care North America. Prior to joining the Company in 2003, he held several senior executive positions at Philips Medical Systems, Perkin Elmer and Baxter Healthcare Corporation, among others. He is Member of the Management Board of Fresenius Medical Care Holdings, Inc., U. S. (Member of the Board of Directors).

Rolf Classon

Mr. Rolf A. Classon has been Independent Member of the Supervisory Board at Fresenius Medical Care AG & Co. KGaA since May 11, 2011. He is Vice Chairman of the Audit and Corporate Governance Committee and Member of the Nomination Committee and the Joint Committee at the Company. He is Member of the Supervisory Board of Fresenius Medical Care Management AG as well as Member of the Board of Directors of Hill-Rom Holdings, Inc., U. S. (Chairman), Tecan Group Ltd., Switzerland (Chairman), Catalent, Inc., U. S. (Non-Executive Director) and Perrigo Company plc, Ireland (Non-Executive Director, since May 8, 2017).

Deborah Doyle McWhinney

Ms. Deborah Doyle McWhinney has been Independent Member of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA since May 12, 2016. She is Member of the Audit and Corporate Governance Committee at the Company. She serves at Lloyds Banking Group plc, Great Britain (Non-Executive Director), Fluor Corporation, U. S. (Non-Executive Director) and IHS Markit Ltd., Great Britain (Non-Executive Director).

William Johnston

Mr. William P. Johnston has been Independent Member of the Supervisory Board at Fresenius Medical Care AG & Co. KGaA since May 9, 2006. Additionally, he acts as Chairman of the Audit and Corporate Governance Committee and Member of the Joint Committee at the Company. He is former Chairman of the Board of Directors of Renal Care Group, Inc. He is also Operating Executive of The Carlyle Group L. P., U. S., Member of the Supervisory Board of Fresenius Medical Care Management AG as well as Member of the Board of Directors of The Hartford Mutual Funds, Inc., U. S. (Chairman) and HCR-Manor Care, Inc., U. S. (Non-Executive Director).

Pascale Witz

Ms. Pascale Witz has been Independent Member of the Supervisory Board of Fresenius Medical Care AG & Co. KGaA since May 12, 2016. She is Member of the Board of Directors of Savencia S. A., France (Non-Executive Director), Horizon Pharma plc, U. S. (Non-Executive Director, since August 3, 2017), Regulus Therapeutics Inc., U. S. (Non-Executive Director, since June 1, 2017), Perkin Elmer Inc., U. S. (Non-Executive Director, since October 30, 2017), PWH Advisors SASU, France (President and Chief Executive Officer, since November 10, 2017).

Dominik Heger

Basic Compensation

Name Fiscal Year Total

Gerd Krick

386,000

Rice Powell

7,532,000

Ben Lipps

4,862,000

Dieter Schenk

236,000

Michael Brosnan

4,380,000

Olaf Schermeier

2,848,000

Harry de Wit

2,572,000

William Valle

2,120,000

Kent Wanzek

3,410,000

Rolf Classon

261,000

Deborah Doyle McWhinney

138,000

William Johnston

313,000

Pascale Witz

92,000

Dominik Heger

--
As Of  31 Dec 2017